Creon 38000 [USP'U]/1

Creon 38000 is a pancreatic enzyme replacement therapy designed to aid digestion in individuals with exocrine pancreatic insufficiency. This delayed-release capsule contains pancrelipase to help break down fats, proteins, and carbohydrates. Ideal for managing digestive health, Creon 38000 supports nutrient absorption and alleviates digestive discomfort.

Creon 38000 is primarily used to manage exocrine pancreatic insufficiency, a condition where the pancreas does not produce enough digestive enzymes. This medication helps break down fats, proteins, and carbohydrates in the digestive system, aiding in nutrient absorption. It is often prescribed for individuals with chronic pancreatitis, cystic fibrosis, or those who have undergone pancreatic surgery. Creon 38000 is taken orally and is designed to release enzymes in the small intestine, where they are most needed.

Common effects of Creon 38000 may include improved digestion and reduced symptoms of malabsorption, such as bloating, gas, and diarrhea. Some users may experience mild gastrointestinal discomfort or changes in bowel movements. These effects are generally temporary and should be discussed with a healthcare provider if they persist or worsen.

Creon 38000 should be stored at room temperature and kept out of reach of children. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Do not crush or chew the capsules, as this can affect the delayed-release mechanism. Always inform your healthcare provider about any other medications you are taking to avoid potential interactions.

Creon 38000 may interact with certain medications, including antacids and other digestive enzymes. It is important to discuss all current medications with a healthcare provider to ensure safe and effective use. Additionally, some dietary supplements and over-the-counter products may affect the absorption or efficacy of Creon 38000.